{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:18:45Z","timestamp":1790900325189,"version":"4.1.0"},"reference-count":23,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,23]]},"DOI":"10.5334\/tohm.682","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:17:39Z","timestamp":1648037859000},"source":"Crossref","is-referenced-by-count":15,"title":["Treatment Patterns in Essential Tremor: A Retrospective Analysis"],"prefix":"10.5334","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-5722","authenticated-orcid":false,"given":"Chintan","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-0331","authenticated-orcid":false,"given":"George R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-6698","authenticated-orcid":false,"given":"Aliya I.","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-4518","authenticated-orcid":false,"given":"Pitchaiah","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3311-1351","authenticated-orcid":false,"given":"Fariha","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"1","key":"key20220323081725_B1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5334\/tohm.632","article-title":"How Common is Essential Tremor? Update on the Worldwide Prevalence of Essential Tremor","volume":"11","year":"2021","journal-title":"Tremor and Other Hyperkinetic Movements"},{"issue":"5","key":"key20220323081725_B2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor","volume":"25","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"key20220323081725_B3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","year":"2018","journal-title":"Mov Disord"},{"issue":"7","key":"key20220323081725_B4","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence-based review of treatments for essential tremor","volume":"34","year":"2019","journal-title":"Mov Disord"},{"issue":"12","key":"key20220323081725_B5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","year":"2005","journal-title":"Neurology"},{"key":"key20220323081725_B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5334\/tohm.239","article-title":"Defining the Treatment Gap: What Essential Tremor Patients Want That They Are Not Getting","volume":"5","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"6","key":"key20220323081725_B7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.410350613","article-title":"The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group","volume":"35","year":"1994","journal-title":"Ann Neurol"},{"issue":"9","key":"key20220323081725_B8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.parkreldis.2010.07.011","article-title":"Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists","volume":"16","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"key20220323081725_B9","first-page":"43","article-title":"Pharmacotherapy of essential tremor","volume":"5","year":"2013","journal-title":"J Cent Nerv Syst Dis"},{"issue":"6","key":"key20220323081725_B10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1468-1331.2009.02926.x","article-title":"How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings","volume":"17","year":"2010","journal-title":"Eur J Neurol"},{"issue":"1","key":"key20220323081725_B11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1353-8020(03)00070-1","article-title":"Use of primidone in low doses (250 mg\/day) versus high doses (750 mg\/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up","volume":"10","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"key20220323081725_B12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mds.10083","article-title":"Randomized trial comparing primidone initiation schedules for treating essential tremor","volume":"17","year":"2002","journal-title":"Mov Disord"},{"issue":"5","key":"key20220323081725_B13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"key20220323081725_B14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","year":"2000","journal-title":"Mov Disord"},{"issue":"3","key":"key20220323081725_B15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/WNL.37.3.471","article-title":"Kinetic predominant essential tremor: successful treatment with clonazepam","volume":"37","year":"1987","journal-title":"Neurology"},{"issue":"9","key":"key20220323081725_B16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jnnp.44.9.814","article-title":"Metoprolol and propranolol in essential tremor: a double-blind, controlled study","volume":"44","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"key20220323081725_B17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archneur.1984.04050140069026","article-title":"Metoprolol compared with propranolol in the treatment of essential tremor","volume":"41","year":"1984","journal-title":"Arch Neurol"},{"issue":"5","key":"key20220323081725_B18","first-page":"547","article-title":"Atenolol vs. propranolol in essential tremor. A controlled, quantitative study","volume":"66","year":"1982","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"key20220323081725_B19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","year":"1996","journal-title":"Mov Disord"},{"issue":"11","key":"key20220323081725_B20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"key20220323081725_B21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/cjn.2017.260","article-title":"Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics","volume":"45","year":"2018","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"key20220323081725_B22","article-title":"Botulinum Toxin for the Treatment of Hand Tremor","volume":"10","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"7","key":"key20220323081725_B23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.36.7.1001","article-title":"Disability in essential tremor: effect of treatment","volume":"36","year":"1986","journal-title":"Neurology"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/doi.org\/10.5334\/tohm.682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:25:49Z","timestamp":1657531549000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.682\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3,23]]}},"alternative-id":["10.5334\/tohm.682"],"URL":"https:\/\/doi.org\/10.5334\/tohm.682","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"10"}}